AG
RDY icon

Advisor Group’s Dr. Reddy's Laboratories RDY Stock Holding History

Advisor Group’s Portfolio RDY Stock Details RDY Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2019
Q4 		$150K Sell
18,625
-415
-2% -$3.28K ﹤0.01% 2619
2019
Q3 		$145K Buy
19,040
+580
+3% +$4.31K ﹤0.01% 2586
2019
Q2 		$138K Buy
18,460
+11,565
+168% +$90.9K ﹤0.01% 2606
2019
Q1 		$56K Buy
6,895
+2,000
+41% +$15.2K ﹤0.01% 3300
2018
Q4 		$37K Buy
4,895
+2,915
+147% +$20.5K ﹤0.01% 3404
2018
Q3 		$14K Sell
1,980
-375
-16% -$2.51K ﹤0.01% 4093
2018
Q2 		$16K Hold
2,355
– – ﹤0.01% 3842
2018
Q1 		$16K Buy
2,355
+30
+1% +$210 ﹤0.01% 3823
2017
Q4 		$17K Buy
2,325
+365
+19% +$2.63K ﹤0.01% 3803
2017
Q3 		$14K Sell
1,960
-225
-10% -$1.62K ﹤0.01% 3779
2017
Q2 		$19K Buy
2,185
+325
+17% +$2.64K ﹤0.01% 3531
2017
Q1 		$15K Sell
1,860
-2,405
-56% -$20.8K ﹤0.01% 3553
2016
Q4 		$38K Sell
4,265
-475
-10% -$4.42K ﹤0.01% 2809
2016
Q3 		$44K Buy
4,740
+1,015
+27% +$9.69K ﹤0.01% 2634
2016
Q2 		$36K Buy
+3,725
New +$34.1K ﹤0.01% 2653

Other funds holding RDY

Royal Bank of Canada
Royal Bank of Canada Toronto, Ontario, Canada $570B AUM 27.57% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
AG
Aperio Group Sausalito, California $33.8B AUM 31.46% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return
Wellington Management Group
Wellington Management Group Boston, Massachusetts $535B AUM 26.23% 1-Year Est. Return
PPA
Parametric Portfolio Associates Seattle, Washington $190B AUM 18.52% 1-Year Est. Return

Advisor Group's RDY Position: Q4 2019 in Review

Advisor Group reduced its Dr. Reddy's Laboratories (RDY) stake by 2.2% in Q4 2019, selling an estimated $3.28K and leaving 18,625 shares worth $150K. The position accounts for ﹤0.01% of the portfolio, ranked #2619.

Advisor Group first reported a position in RDY in Q2 2016 and has held it in 15 quarters since. 148 funds tracked by Wall St. Rank hold RDY as of Q4 2019.

  • Advisor Group held 18,625 shares of Dr. Reddy's Laboratories worth $150K as of Q4 2019.
  • Advisor Group sold 415 Dr. Reddy's Laboratories shares in Q4 2019, an estimated $3.28K.
  • Dr. Reddy's Laboratories made up ﹤0.01% of Advisor Group's portfolio in Q4 2019, its #2619 holding.
  • Advisor Group first reported a position in Dr. Reddy's Laboratories in Q2 2016 and has held it in 15 quarters since.
  • 148 funds tracked by Wall St. Rank held Dr. Reddy's Laboratories as of Q4 2019.

Based on Advisor Group's 13F filing for Q4 2019, filed 12 Feb 2020.